Current concepts in the evaluation and treatment of neurofibromatosis type II

Brian A Neff; D Bradley Welling

doi:10.1016/j.otc.2005.01.002

Current concepts in the evaluation and treatment of neurofibromatosis type II

Otolaryngol Clin North Am. 2005 Aug;38(4):671-84, ix. doi: 10.1016/j.otc.2005.01.002.

Authors

Brian A Neff¹, D Bradley Welling

Affiliation

¹ Department of Otolaryngology, Mayo Clinic, Rochester, MN, USA.

PMID: 16005725
DOI: 10.1016/j.otc.2005.01.002

Abstract

This article presents the current diagnostic and treatment options for the hereditary disease neurofibromatosis type II, reviews clinical presentation and diagnosis, highlights indications for and methods of clinical and genetic screening, discusses treatment approaches for surgery and stereotactic radiation, and summarizes potential future therapeutic avenues.

Publication types

Review

MeSH terms

Decompression, Surgical
Genetic Testing
Hearing Loss / rehabilitation
Humans
Magnetic Resonance Imaging
Neurofibromatosis 2 / diagnosis*
Neurofibromatosis 2 / genetics
Neurofibromatosis 2 / physiopathology
Neurofibromatosis 2 / radiotherapy
Neurofibromatosis 2 / therapy*